PTGX Net Margin
29.40%TTM
Period ending:
PTGX FY Net Margin%
4080.66%-37431.60%
2014-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
PTGX net margin history
Net income as a percentage of revenue. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.
| Period ending | Net Margin |
|---|---|
| -282.8342% | |
| 63.3442% | |
| -131.5917% | |
| -479.2634% | |
| -458.9356% | |
| -231.0675% | |
| -33,414.2857% | |
| -125.8658% | |
| -184.2048% | |
| 0% | |
| 0% | |
| 0% |
Compare net margin
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) net margin
- Bridgebio Pharma Inc (BBIO) net margin
- Brightspring Health Services Inc (BTSG) net margin
- Madrigal Pharmaceuticals Inc (MDGL) net margin
- Ensign Group Inc (ENSG) net margin
- Glaukos Corp (GKOS) net margin
- Krystal Biotech Inc (KRYS) net margin
- Twist Bioscience Corp (TWST) net margin
Compare all covered stocks by net margin →
All PTGX financial metrics · PTGX stock overview · How to interpret financial metrics
